Tsuruya, Kazuhiko
,
Hayashi, Terumasa
Yamamoto, Hiroyasu
Hase, Hiroki
Nishi, Shinichi
Yamagata, Kunihiro
Nangaku, Masaomi
Wada, Takashi
Uemura, Yukari
Ohashi, Yasuo
Hirakata, Hideki
Funding for this research was provided by:
Chugai Pharmaceutical
Article History
Received: 15 April 2020
Accepted: 30 November 2020
First Online: 7 January 2021
Compliance with ethical standards
:
: K. Tsuruya has received speakers fee as honoraria and grants from Chugai and Kyowa Kirin. T. Hayashi has received speakers fee as honoraria from Chugai and Kyowa Kirin. H. Yamamoto has received speakers fee as honoraria from Chugai and Kyowa Kirin. H. Hase has received grants from Chugai and Kyowa Kirin. S. Nishi has received speakers fee as honoraria and grants from Chugai and Kyowa Kirin. K. Yamagata has received speakers fee as honoraria and grants from Chugai and Kyowa Kirin. M. Nangaku has received speakers fee as honoraria from Chugai, Kyowa Kirin and Kissei, grants from Chugai and Kyowa Kirin, research funding from Kyowa Kirin and manuscript fee from Kyowa Kirin. T. Wada has received grants from Chugai and Kyowa Kirin, and research funding from Kyowa Kirin. Y. Uemura has received speakers fee as honoraria from Chugai. Y. Ohashi has received speakers fee as honoraria from Chugai. H. Hirakata has speakers fee as honoraria from Chugai.
: This study was conducted in compliance with the Declaration of Helsinki and “Ethical Guidelines for Clinical Studies” by the Ministry of Health, Labour and Welfare and in accordance with International Council for Harmonization Good Clinical Practice (ICH-GCP) guidelines. The study was approved by an independent central ethics committee and was registered in the University Hospital Medical Information Network (UMIN) database (UMIN000008617). Study treatments performed were covered by ordinary health insurance. This report was prepared according to the Consolidated Standards of Reporting Trials (CONSORT).
: Written informed consent was obtained from all included participants included in the study.